Emerging CAR T cell therapies: clinical landscape and patent technological routes
The purpose of this study is to mine CAR-T patents and therapies under development, to design a landscape of the sector and to understand key therapy segments and their current trends. The study analyzed the entire market, consisting of 1624 patent families and 509 biologics under development, to de...
Saved in:
Main Authors: | Virgínia Picanco-Castro (Author), Cristiano Gonçalves Pereira (Author), Kamilla Swiech (Author), Kelen Cristina Ribeiro Malmegrim (Author), Dimas Tadeu Covas (Author), Geciane Silveira Porto (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-based cell therapy: evaluation with bibliometrics and patent analysis
by: Yajun Yuan, et al.
Published: (2021) -
Patent landscape of neglected tropical diseases: an analysis of worldwide patent families
by: Folahanmi Tomiwa Akinsolu, et al.
Published: (2017) -
Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
by: Manuela Berto Pucca, et al.
Published: (2011) -
The global mRNA vaccine patent landscape
by: Mengyao Li, et al.
Published: (2022) -
Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization
by: Amanda Mizukami, et al.
Published: (2018)